300765.SZ
石药创新
SZSE · Consumer Defensive · C 制造业 · CN
CNY 45.24
−7.67%Year over year
Reported trailing growth
- Revenue
- +21.9%
- EBITDA
- —
- EBIT
- -34.0%
- EPS
- —
- Free cash flow
- -0.4%
- Operating cash flow
- +16.8%
Forward estimates
Based on analyst estimates
- Revenue
- +11.3%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -6.3%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +55.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026